Home Stock

Stock Research: Dr. Lal PathLabs

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Dr. Lal PathLabs

NSI:LALPATHLAB INE600L01024
45
  • Value
    10
  • Growth
    38
  • Safety
    Safety
    70
  • Combined
    34
  • Sentiment
    65
  • 360° View
    360° View
    45
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The company offers a range of diagnostic services including core testing, patient diagnosis, prevention, monitoring, and treatment of various diseases, with tests such as Pregnancy Test, Full Body Checkups, Covid 19 Test, and more. It operates throughout India. In the last fiscal year, the company had a market cap of $2902 millions, profits of $229 millions, revenue of $288 millions, and 4980 employees.

more

ANALYSIS: With an Obermatt 360° View of 45 (better than 45% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dr. Lal PathLabs are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Dr. Lal PathLabs. The consolidated Sentiment Rank has a good rank of 65, which means that professional investors are more optimistic about the stock than for 65% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 70 or better than 70% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 10, meaning that the share price of Dr. Lal PathLabs is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 38. ...read more

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank Pro Holdings
Country India
Industry Health Care Services
Size Medium
Website lalpathlabs.com
Index
Dr. Lal PathLabs stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 9 1 1
Growth
38 53 83 91
Safety
Safety
70 61 50 56
Sentiment
65 13 37 6
360° View
360° View
45 12 27 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
36 29 3 7
Opinions Change
75 28 50 32
Pro Holdings
n/a 53 77 56
Market Pulse
52 24 65 41
Sentiment
65 13 37 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 9 1 1
Growth
38 53 83 91
Safety Safety
70 61 50 56
Combined
34 22 42 46
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
7 11 7 1
Price vs. Earnings (P/E)
13 17 7 1
Price vs. Book (P/B)
7 10 10 1
Dividend Yield
56 42 26 23
Value
10 9 1 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
75 65 62 45
Profit Growth
59 52 75 70
Capital Growth
16 32 90 81
Stock Returns
50 65 33 91
Growth
38 53 83 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
69 56 50 72
Refinancing
48 31 27 27
Liquidity
65 63 53 59
Safety Safety
70 61 50 56

Similar Stocks

Discover high‑ranked alternatives to Dr. Lal PathLabs and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Fleury

SAO:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Large
Full Stock Analysis

Ramkhamhaeng Hospital

SET:RAM
Country: Thailand
Industry: Health Care Facilities
Size: Medium
Full Stock Analysis

CESC

NSI:CESC
Country: India
Industry: Electric Utilities
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews